Virology Testing Market Application 2020 – Industry Trends, Global Analysis, Technology, Business Growth & Demand, Top 5 Leading Players, Sectors & Services and Forecast by 2026
Virology Testing Market – Competitive Landscape
Some of the key players operating in the virology testing market include F. Hoffmann-La Roche AG., Bio-Rad Laboratories Inc., Hologic Inc., Abbot Healthcare, Fujirebio Diagnostics Inc., Thermo Fisher Scientific Inc., Cepheid, bioMerieux SA, Qiagen, Diasorin, Scienion AG, Siemens AG Grifols, Eiken Chemical Co Ltd., Sequenom, and Diamedix Inc.
Virology testing consist of diagnostic methods that help in early detection of diseases such as hepatitis, influenza, HIV, sexually transmitted disease, RCV, and other viral associated diseases. Virology testing examines for detection of viral antigens, nucleic acids, and antibodies in the given sample, in order to confirm the presence of particular viral infection. There are over 100 viral diseases identified.
Request a sample copy of this report@ https://www.coherentmarketinsights.com/insight/request-sample/2037
Moreover, in order to confirm viral infections, virology testing inculcates various methods. Culture medium-based method, in which virus is confirmed by colony formation over culture has been traditionally used since long time. Although this method is widely acceptable and easy to perform, it is often time-consuming, as it takes few days to weeks to confirm presence of particular virus. It is a serious limitation especially in viral pandemics where loss of time could result in more widespread infection and delay in management of the viral infection.
New advanced molecular-based virology testing methods has been evolved in the recent past such as immunoassay, nucleic acid-based amplification testing methods (PCR-based methods), mass spectrometry-based detection methods, and next-generation genome sequencing methods, which are accurate, quick, and provides result for diversified viral infections.
Tailored Information as per niche requirement:
LIMITED TIME OFFER – Hurry Up!
Get Discount For Buyers UPTO 30% OFF On Any Research Report
Apply Promo Code “CMIFIRST1000” And Get Instant Discount Of USD 1000
Buy Now This Premium Report to Grow your Business @ https://www.coherentmarketinsights.com/insight/buy-now/2037
Virology Testing Market-Market Dynamics
Virology testing market is expected to witness significant growth during the forecast period with rising prevalence of virus originated diseases such as flu, hepatitis, AIDS, and STDs, Ebola, Influenza-based viral infections, severe acute respiratory syndrome from coronavirus, hemorrhagic fever, and others across the globe. For instance, according to the World Health Organization (WHO), January 2018 factsheet, all types of influenza in combination causes annual epidemics about 3 to 5 million cases with severe stage of illness, which results in 290,000 to 650,000 deaths worldwide annually. Although rapid diagnostic tests are majorly used, PCR based-techniques are being adopted for detection of influenza.
According to a report on Global Sexually Transmitted Infection Surveillance published in 2015 by WHO, in 2012, around 357 million new infections, which is equivalent to roughly 1 million patients per day were reported for the four curable sexually transmitted disease such as chlamydia, gonorrhea, syphilis, and trichomoniasis.
Furthermore, advances in anti-viral therapy in terms of detection techniques, medication, and vaccines are expected to drive the virology testing market growth. Market palyers are focused on developing novel vaccines and novel medication for treating viral resistant diseases. For instance, Pritelivir is investigational drug for herpes simplex virus (HSV) by AiCuris has proven to be very effective as compared to the current standard antiviral treatments for genital herpes in Phase II trials. Extensive research has been conducted worldwide for treatment of high epidemic viral disease such as Ebola, Dengue, and Malaria.
New technologies for detecting and curing viral disease aids in market expansion. For instance, the nanoscale viral trap molecule technology, which is under research at present can be applicable in diagnosing a viral disease. An innovative tunable device selectively traps viruses detecting them with 100 times better sensitivity than the current available techniques. Double-stranded RNA Activated Caspase Oligomerizer (DRACO) is another nanoparticle-based drug in research to treat viral disease.
To understand Research Methodology, please click https://www.coherentmarketinsights.com/ongoing-insight/virology-testing-market-2037
Virology Testing Market – Regional Insights
On the basis of region, virology testing market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa. North America is expected to hold dominant position in the virology testing market over the forecast period. According to the Centers for Disease Control and Prevention (CDC), around 5,251 deaths were reported due to influenza infection in 2015.
According to the National Ambulatory Medical Care Survey: 2015 data findings, around 16.8 million people visited physician for the treatment of infectious and parasitic diseases in the U.S. Moreover, according to a study from the Society for Risk Analysis, 2016, GDP loss of a viral pandemic outbreak in the U.S. was recorded between US$ 34.4 billion and US$ 45.3 billion in 2015.
Furthermore, robust healthcare infrastructure and highest healthcare spending in world makes the U.S. most lucrative market. However, Asia Pacific is expected to exhibit high CAGR due to outbreak of viral influenza and largest patient pool infected with HIV in the region.
- In 2018, Bruker Corporation acquired Hain Lifescience GmbH, a molecular diagnostics company. This acquisiotn will expand the Bruker Corporation’s molecular diagnostic product portfolio.
- In 2018, QIAGEN N.V. and NeuMoDx Molecular, Inc. entered into strategic partnership to commercialize two new fully integrated systems for automation of PCR (polymerase chain reaction) testing. These next-generation systems are specifically designed to help clinical molecular diagnostic laboratories process.
- In 2017, Quidel Corporation entered into definitive agreement to acquire Triage MeterPro cardiovascular (CV) and toxicology assets and the B-type Naturietic Peptide (BNP) assay business from Alere Inc.
- In 2015, Eurofins Scientific acquired Diatherix Laboratories, Inc., which offers clinical laboratories services on a multiplexing platform for the detection of infectious diseases.
Request a Customization: https://www.coherentmarketinsights.com/insight/request-customization/2037
Virology Testing Market – Market Taxonomy
The global virology testing market is segmented on the basis of diagnostic technique, product type, end-user, and region
By Diagnostic Technique:
- Molecular Diagnostics Method
- PCR-based Methods
- NGS-based Methods
- Immunoassay-based Method
- Mass Spectroscopy-based Method
By Product Type:
- Assay Kits and Consumables
By End User:
- Diagnostic Centers
- Blood Banks
- North America
- Latin America
- Asia Pacific
- Middle East
Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies, to not-for-profit organization, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.
To know more about us, please visit our website – www.coherentmarketinsights.com
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
- CDN Newswire